Figure 3. Changes to gastrointestinal symptoms experienced since starting on a CFTR modulator.
3a: PwCF were asked to compare how their symptoms had been in the last 4 weeks, compared to prior to initiating modulator therapy. 3b: Reporting of gastrointestinal symptoms to HCPs in those people taking a CFTR modulator.